Article
The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
Cell death and differentiation - 1 May 2007
Shapira S, Barkan B, Friedman E, Fridman E, Kloog Y, Stein R
Abstract excerpt
Neurofibromatosis type 1 (NF1) is characterized by a high incidence of benign and malignant tumors attributed to loss of function of Nf1, which encodes neurofibromin, a tumor suppressor with Ras-GAP activity. Neurofibromin deficiency typically causes chronic activation of Ras, considered the major contributor to manifestation of NF1. Resistance to radio- and chemotherapy are typical of NF1-associated tumors, but...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
